• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group.加州双箭形水蚤乙酰胆碱酯酶被双降诺司卡品抑制的动力学及其离去基团复合物的晶体结构。
Biochem J. 2012 Jun 1;444(2):269-77. doi: 10.1042/BJ20111675.
2
The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase.抗癌前药CPT - 11与加州电鳐乙酰胆碱酯酶的三维结构揭示了其对乙酰胆碱酯酶的抑制作用以及被丁酰胆碱酯酶和羧酸酯酶水解的机制。
Chem Biol Interact. 2005 Dec 15;157-158:153-7. doi: 10.1016/j.cbi.2005.10.016. Epub 2005 Nov 14.
3
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.与E2020(安理申)复合的乙酰胆碱酯酶结构:对新型抗阿尔茨海默病药物设计的启示
Structure. 1999 Mar 15;7(3):297-307. doi: 10.1016/s0969-2126(99)80040-9.
4
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).新型口服活性氨基甲酸酯类抗阿尔茨海默病药物甘斯的明(CHF-2819)对加州电鳐乙酰胆碱酯酶抑制作用的结构决定因素
J Med Chem. 2006 Aug 24;49(17):5051-8. doi: 10.1021/jm060293s.
5
Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.E2020与加州电鳐乙酰胆碱酯酶复合物的三维结构。
J Physiol Paris. 1998 Jun-Aug;92(3-4):191-4. doi: 10.1016/s0928-4257(98)80008-9.
6
Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.利用分子对接准确预测加兰他敏在加州电鳐乙酰胆碱酯酶活性位点的结合构象。
J Mol Graph Model. 2001;19(3-4):288-96, 374-8. doi: 10.1016/s1093-3263(00)00056-5.
7
Targeted oxidation of Torpedo californica acetylcholinesterase by singlet oxygen: identification of N-formylkynurenine tryptophan derivatives within the active-site gorge of its complex with the photosensitizer methylene blue.靶向氧化加利福尼亚虎纹蛙乙酰胆碱酯酶的单线态氧:鉴定其与光敏剂亚甲蓝复合物的活性位点峡谷内的 N-甲酰犬尿氨酸色氨酸衍生物。
Biochem J. 2012 Nov 15;448(1):83-91. doi: 10.1042/BJ20120992.
8
The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.加兰他敏二价衍生物与电鳐乙酰胆碱酯酶的复合物显示出活性位点峡谷的剧烈变形:对基于结构的药物设计的启示。
J Am Chem Soc. 2004 Dec 1;126(47):15405-11. doi: 10.1021/ja0466154.
9
"Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase.氨基甲酰化乙酰胆碱酯酶晶体结构所暗示的“后门”开放。
Biochemistry. 1999 May 4;38(18):5714-9. doi: 10.1021/bi982723p.
10
Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.
Biochemistry. 2002 Mar 19;41(11):3555-64. doi: 10.1021/bi020016x.

引用本文的文献

1
Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.合成及初步鉴定一种对人丁酰胆碱酯酶具有选择性、拟不可逆抑制作用的新型正电子发射断层显像剂。
ChemMedChem. 2021 May 6;16(9):1427-1437. doi: 10.1002/cmdc.202000942. Epub 2021 Mar 1.
2
Toward Simple, Predictive Understanding of Protein-Ligand Interactions: Electronic Structure Calculations on Torpedo Californica Acetylcholinesterase Join Forces with the Chemist's Intuition.朝向对蛋白质-配体相互作用的简单、可预测理解:加利福尼亚美洲电鳐乙酰胆碱酯酶的电子结构计算与化学家的直觉相结合。
Sci Rep. 2020 Jun 8;10(1):9218. doi: 10.1038/s41598-020-65984-0.
3
Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.基于药效团的(-)-美普他酚氨基甲酸酯类化合物的设计与发现:作为胆碱酯酶和淀粉样蛋白生成的双重调节剂
J Enzyme Inhib Med Chem. 2017 Dec;32(1):659-671. doi: 10.1080/14756366.2016.1265521.
4
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.体内活性可逆丁酰胆碱酯酶抑制剂的研制。
Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495.
5
Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂与免疫相遇。
Int J Mol Sci. 2014 Jun 2;15(6):9809-25. doi: 10.3390/ijms15069809.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
ENZO: a web tool for derivation and evaluation of kinetic models of enzyme catalyzed reactions.ENZO:一个用于推导和评估酶催化反应动力学模型的网络工具。
PLoS One. 2011;6(7):e22265. doi: 10.1371/journal.pone.0022265. Epub 2011 Jul 19.
3
Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations.基于 X 射线晶体学和分子动力学模拟的乙酰胆碱酯酶中的后门开口机制。
Protein Sci. 2011 Jul;20(7):1114-8. doi: 10.1002/pro.661. Epub 2011 Jun 10.
4
Aromatic rings in chemical and biological recognition: energetics and structures.化学和生物识别中的芳环:能量学和结构。
Angew Chem Int Ed Engl. 2011 May 16;50(21):4808-42. doi: 10.1002/anie.201007560. Epub 2011 Apr 28.
5
Overview of the CCP4 suite and current developments.CCP4软件包概述及当前进展
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.
6
Long route or shortcut? A molecular dynamics study of traffic of thiocholine within the active-site gorge of acetylcholinesterase.长路径还是捷径?乙酰胆碱酯酶活性部位峡谷内硫代胆碱流运动的分子动力学研究。
Biophys J. 2010 Dec 15;99(12):4003-11. doi: 10.1016/j.bpj.2010.10.047.
7
Neurochemical basis for symptomatic treatment of Alzheimer's disease.阿尔茨海默病症状治疗的神经化学基础。
Neuropharmacology. 2010 Sep-Oct;59(4-5):221-9. doi: 10.1016/j.neuropharm.2010.02.010. Epub 2010 Feb 13.
8
Cholinesterase inhibitors and beyond.胆碱酯酶抑制剂及其他。
Curr Alzheimer Res. 2009 Apr;6(2):86-96. doi: 10.2174/156720509787602861.
9
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.毒扁豆碱及其类似物与乙酰胆碱酯酶的结合主要由疏水相互作用主导。
Biochem J. 2009 Jan 1;417(1):213-22. doi: 10.1042/BJ20081276.
10
Kinetic evaluation of multiple initial rate data by simultaneous analysis with two equations.
Chem Biol Interact. 2008 Sep 25;175(1-3):242-8. doi: 10.1016/j.cbi.2008.05.017. Epub 2008 May 18.

加州双箭形水蚤乙酰胆碱酯酶被双降诺司卡品抑制的动力学及其离去基团复合物的晶体结构。

Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group.

机构信息

Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Area della Ricerca di Roma, Monterotondo Scalo, Italy.

出版信息

Biochem J. 2012 Jun 1;444(2):269-77. doi: 10.1042/BJ20111675.

DOI:10.1042/BJ20111675
PMID:22390827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4979005/
Abstract

Natural and synthetic carbamates act as pseudo-irreversible inhibitors of AChE (acetylcholinesterase) as well as BChE (butyrylcholinesterase), two enzymes involved in neuronal function as well as in the development and progression of AD (Alzheimer's disease). The AChE mode of action is characterized by a rapid carbamoylation of the active-site Ser(200) with release of a leaving group followed by a slow regeneration of enzyme action due to subsequent decarbamoylation. The experimental AD therapeutic bisnorcymserine, a synthetic carbamate, shows an interesting activity and selectivity for BChE, and its clinical development is currently being pursued. We undertook detailed kinetic studies on the activity of the carbamate bisnorcymserine with Tc (Torpedo californica) AChE and, on the basis of the results, crystallized the complex between TcAChE and bisnorcymserine. The X-ray crystal structure showed only the leaving group, bisnoreseroline, trapped at the bottom of the aromatic enzyme gorge. Specifically, bisnoreseroline interacts in a non-covalent way with Ser(200) and His(440), disrupting the existing interactions within the catalytic triad, and it stacks with Trp(84) at the bottom of the gorge, giving rise to an unprecedented hydrogen-bonding contact. These interactions point to a dominant reversible inhibition mechanism attributable to the leaving group, bisnoreseroline, as revealed by kinetic analysis.

摘要

天然和合成的氨基甲酸酯类作为乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的拟不可逆抑制剂,这两种酶参与神经元功能以及 AD(阿尔茨海默病)的发展和进展。AChE 的作用模式的特点是活性部位 Ser(200)的快速氨甲酰化,随后释放离去基团,然后由于随后的脱氨甲酰化,酶的作用缓慢再生。实验性 AD 治疗药物双去甲辛可司林是一种合成的氨基甲酸酯,对 BChE 显示出有趣的活性和选择性,其临床开发目前正在进行中。我们对 Tc(加利福尼亚海兔)AChE 中氨基甲酸酯双去甲辛可司林的活性进行了详细的动力学研究,并根据结果对 TcAChE 与双去甲辛可司林的复合物进行了结晶。X 射线晶体结构仅显示离去基团双去甲辛可司林被捕获在芳香酶峡谷的底部。具体来说,双去甲辛可司林以非共价方式与 Ser(200)和 His(440)相互作用,破坏催化三联体中的现有相互作用,并与峡谷底部的 Trp(84)堆积,形成前所未有的氢键接触。这些相互作用表明,动力学分析表明,离去基团双去甲辛可司林导致了主要的可逆抑制机制。